- Cumulative ADC Toxicities and Closing Reflections: Managing Edema, Fatigue, and Optimizing Long-Term TolerabilityThis concluding segment addresses cumulative toxicities affecting long-term antibody-drug conjugate tolerability, with Hope Rugo, MD and Aaron Lisberg, MD discussing edema, fatigue, and strategies…onclive · 2mo ago↗ source
- Natalie Holles' next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotech→ It didn’t take long for Natalie Holles to rebound after the decision to wind down operations at her previous company. She has replaced Elisabet de los Pinos as CEO of ...Endpoints · 2mo ago↗ source
- Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prepCapricor Therapeutics said Thursday it has filed a lawsuit against Nippon Shinyaku over a distribution and commercialization agreement for deramiocel, a cell therapy candidate for Duchenne muscular…